BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12548208)

  • 1. Endometritis does not predict reproductive morbidity after pelvic inflammatory disease.
    Haggerty CL; Ness RB; Amortegui A; Hendrix SL; Hillier SL; Holley RL; Peipert J; Randall H; Sondheimer SJ; Soper DE; Sweet RL; Trucco G
    Am J Obstet Gynecol; 2003 Jan; 188(1):141-8. PubMed ID: 12548208
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Wiringa AE; Ness RB; Darville T; Beigi RH; Haggerty CL
    Sex Transm Infect; 2020 Sep; 96(6):436-438. PubMed ID: 31719170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel microbes associated with pelvic inflammatory disease and infertility.
    Haggerty CL; Totten PA; Tang G; Astete SG; Ferris MJ; Norori J; Bass DC; Martin DH; Taylor BD; Ness RB
    Sex Transm Infect; 2016 Sep; 92(6):441-6. PubMed ID: 26825087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.
    Haggerty CL; Totten PA; Astete SG; Lee S; Hoferka SL; Kelsey SF; Ness RB
    Sex Transm Infect; 2008 Oct; 84(5):338-42. PubMed ID: 18445635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute pelvic inflammatory disease.
    Eschenbach DA
    Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole.
    Heinonen PK; Leinonen M
    Arch Gynecol Obstet; 2003 Oct; 268(4):284-8. PubMed ID: 14504870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease.
    Wiesenfeld HC; Hillier SL; Krohn MA; Amortegui AJ; Heine RP; Landers DV; Sweet RL
    Obstet Gynecol; 2002 Sep; 100(3):456-63. PubMed ID: 12220764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial correlates of delayed care for pelvic inflammatory disease.
    Taylor BD; Ness RB; Darville T; Haggerty CL
    Sex Transm Dis; 2011 May; 38(5):434-8. PubMed ID: 21124257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline.
    Wølner-Hanssen P; Paavonen J; Kiviat N; Young M; Eschenbach DA; Holmes KK
    Obstet Gynecol; 1988 Apr; 71(4):595-600. PubMed ID: 3353051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical pelvic inflammatory disease and infertility.
    Wiesenfeld HC; Hillier SL; Meyn LA; Amortegui AJ; Sweet RL
    Obstet Gynecol; 2012 Jul; 120(1):37-43. PubMed ID: 22678036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic inflammatory disease: a review with emphasis on antimicrobial therapy.
    Burnakis TG; Hildebrandt NB
    Rev Infect Dis; 1986; 8(1):86-116. PubMed ID: 2937130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial.
    Ness RB; Trautmann G; Richter HE; Randall H; Peipert JF; Nelson DB; Schubeck D; McNeeley SG; Trout W; Bass DC; Soper DE
    Obstet Gynecol; 2005 Sep; 106(3):573-80. PubMed ID: 16135590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease.
    Haggerty CL; Totten PA; Astete SG; Ness RB
    Infect Dis Obstet Gynecol; 2006; 2006():30184. PubMed ID: 17485798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study.
    Ness RB; Soper DE; Holley RL; Peipert J; Randall H; Sweet RL; Sondheimer SJ; Hendrix SL; Amortegui A; Trucco G; Bass DC; Kelsey SF;
    Am J Obstet Gynecol; 2001 Jul; 185(1):121-7. PubMed ID: 11483915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic Inflammatory Disease Due to Neisseria gonorrhoeae and Chlamydia trachomatis: Immune Evasion Mechanisms and Pathogenic Disease Pathways.
    Darville T
    J Infect Dis; 2021 Aug; 224(12 Suppl 2):S39-S46. PubMed ID: 34396413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study.
    Trent M; Bass D; Ness RB; Haggerty C
    Sex Transm Dis; 2011 Sep; 38(9):879-81. PubMed ID: 21844746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antimicrobial treatment of subacute endometritis: a proof of concept study.
    Eckert LO; Thwin SS; Hillier SL; Kiviat NB; Eschenbach DA
    Am J Obstet Gynecol; 2004 Feb; 190(2):305-13. PubMed ID: 14981366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease?
    Trautmann GM; Kip KE; Richter HE; Soper DE; Peipert JF; Nelson DB; Trout W; Schubeck D; Bass DC; Ness RB
    Am J Obstet Gynecol; 2008 Jan; 198(1):30.e1-7. PubMed ID: 18166300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of lower genital tract inflammation with objective evidence of endometritis.
    Peipert JF; Ness RB; Soper DE; Bass D
    Infect Dis Obstet Gynecol; 2000; 8(2):83-7. PubMed ID: 10805362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commonly used diagnostic criteria for pelvic inflammatory disease have poor sensitivity for plasma cell endometritis.
    Korn AP; Hessol N; Padian N; Bolan G; Muzsnai D; Donegan E; Jonte J; Schachter J; Landers DV
    Sex Transm Dis; 1995; 22(6):335-41. PubMed ID: 8578403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.